Product Images Ryplazim
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Ryplazim NDC 70573-099 by Prometic Biotherapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - ryplazim 01
Figure 2 - ryplazim 02
Figure 3 - ryplazim 03
Figure 4 - ryplazim 04
Fig A - ryplazim 05
Fig B - ryplazim 06
Fig C - ryplazim 07
Fig D - ryplazim 08
PRINCIPAL DISPLAY PANEL - 68.8 mg Vial Label - ryplazim 09
This is a description of Ryplazim®, a human plasminogen used for intravenous use only. The medicine is stored at 2-25 °C and each vial contains 68.8 mg of human plasminogen which is reconstituted in 12.5 ml of sterile water for injection. Ryplazim® is manufactured for Prometic Biotherapeutics, Inc located in Fort Lee, New Jersey, USA by Prometc Bioproducton, Inc located in Laval, Quebec, Canada. Any unused portion should be discarded. A prescription is necessary for purchase.*
PRINCIPAL DISPLAY PANEL - 68.8 mg Vial Carton - ryplazim 10
Ryplazim is a single-dose vial containing 68.8mg human plasminogen that is intended for intravenous use only. The vial must be stored at room temperature and should not be frozen. It is a sterile, preservative-free medicine. Any unused portion should be discarded. The manufacturer is Prometic and the product is produced in Canada and the USA. The medication has a national drug code of 7057309902.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.